• / Free eNewsletters & Magazine
  • / My Account
Home>Global Neuroprosthetics Market 2017-2021: Boosted by Rising Prevalence of SCIs - Research and Markets

Global Neuroprosthetics Market 2017-2021: Boosted by Rising Prevalence of SCIs - Research and Markets

Global Neuroprosthetics Market 2017-2021: Boosted by Rising Prevalence of SCIs - Research and Markets

10/05/2017

Global Neuroprosthetics Market 2017-2021: Boosted by Rising Prevalence of SCIs - Research and Markets

The "Global Neuroprosthetics Market 2017-2021" report has been added to Research and Markets' offering.

The global neuroprosthetics market is forecast to grow at a CAGR of 7.08% during the period 2017-2021.

The report, Global Neuroprosthetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of theKey vendors operating in this market.

The latest trend gaining momentum in the market is the increasing focus on research. Various scientific publications have recognized the effectiveness of neuroprosthetics devices such as regaining and increasing muscle strength and continence, providing pain relief, and restoring body movement including limbs and arms. Over the years, there have been dedicated research involving the use of neuroprosthetics devices such as deep brain stimulators and nerve stimulators, which use electric current to stimulate the paralyzed muscle that is damaged or disabled. These researches aim to provide greater mobility to the individual being treated for rehabilitation condition or with any neurological disorders.

According to the report, one of the major drivers for this market is the rising prevalence of SCIs. There is an increasing demand for neuroprosthetics due to its significant usage in the treatment of SCI. The neuroprosthetics devices help in restoring function and sensation of individuals with SCI and have a positive impact on the sales of neuroprosthetics devices in the global market. According to the National Institutes of Health (NIH), approximately 12,000 new cases of SCIs have reported annually.

Key vendors

  • Abbott (St. Jude Medical)
  • Boston Scientific
  • Cochlear
  • Medtronic
  • Sonova

Key Topics Covered:

©2017 Morningstar Advisor. All right reserved.